About Conference

On behalf of the organizing committee, it is with great pleasure and anticipation that we extend a warm welcome to you for the 7th Annual Meeting on Diabetes and Endocrinology, scheduled to take place in the captivating city of Paris, France, on November 27-28, 2024. Endocrinology Meet 2024 promises to be a remarkable platform for exchanging cutting-edge research, innovative ideas, and best practices in the field of diabetes and endocrinology. We look forward to your invaluable contributions and the opportunity to forge enduring connections in this vibrant scientific community. Prepare to be inspired, enlightened, and empowered as we embark on this journey together towards enhancing patient care and shaping the future of diabetes and endocrinology. We are excited to facilitate dynamic discussions, foster collaborations, and ultimately advance our collective understanding and management of these critical health issues.

Scope and importance

The Endocrinology Meet 2024 conference serves as a vital platform for professionals in the field to explore the latest developments and challenges in endocrinology. This conference offers a comprehensive scope covering diverse topics such as diabetes, thyroid disorders, hormonal imbalances, reproductive health, and more. By bringing together clinicians, researchers, educators, and industry leaders, it facilitates interdisciplinary collaboration, fosters knowledge exchange, and promotes innovative approaches to diagnosis, treatment, and prevention. The conference's importance lies in its ability to drive forward-thinking discussions, share cutting-edge research findings, and ultimately advance our understanding and management of endocrine disorders.

Why to attend?

Attending the Endocrinology Meet 2024 conference is essential for anyone involved in the field of endocrinology. This gathering offers a unique platform to stay updated on the latest research, breakthroughs, and advancements in endocrine disorders and treatments. Through engaging presentations, interactive sessions, and networking opportunities, attendees can expand their knowledge, exchange ideas, and establish valuable connections with peers and experts.

Who can attend?

The Endocrinology Meet 2024 conference welcomes a diverse audience, including endocrinologists, researchers, clinicians, healthcare professionals, educators, students, and industry representatives. With sessions tailored to various interests and expertise levels, attendees can engage in discussions, share insights, and stay updated on the latest advancements in the field.

Target Audience

• Endocrinologists
• Diabetologists
• Diabetes educators
• Researchers in endocrinology and diabetes
• Clinical researchers
• Healthcare professionals
• Dietitian
• Neurologists
• Ophthalmologist
• Cardiologists
• Nephrologists
• Diabetes societies & associations
• Medical & Pharmaceutical companies
• Primary care physicians
• Nurse practitioners
• Pharmacists
• Students
• Industry professionals
• Policy makers

Sessions

Track 1: Overview of Diabetes

Providing a comprehensive understanding of diabetes mellitus, covering its epidemiology, etiology, pathophysiology, and diagnostic criteria to lay the foundation for subsequent discussions on management and complications. Keynote speakers, including leading endocrinologists and researchers, will discuss advances in glucose monitoring, insulin therapy, and emerging technologies in diabetes care.

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Diabetes Mellitus

Track 2: Diabetic Complications

Exploring the multifaceted complications arising from diabetes, including microvascular (retinopathy, nephropathy) and macrovascular (cardiovascular disease, neuropathy) complications, alongside strategies for prevention, early detection, and optimal management. The session will also highlight the importance of integrated care approaches, patient education, and lifestyle modifications in reducing the risk and severity of diabetic complications.

• Foot Complications
• Gastroparesis
• Hypoglycemia

Track 3: Obesity-Related Diabetes

Investigating the intricate relationship between obesity and diabetes, focusing on the mechanisms linking adiposity, insulin resistance, and metabolic dysfunction, and exploring tailored approaches to managing diabetes in the context of obesity. Experts will also discuss strategies for effective lifestyle interventions, patient education, and long-term management to prevent and treat obesity-related diabetes.

• Beta Cell Dysfunction
• Inflammation
• Dyslipidemia
• Central Obesity

Track 4: Insulin Therapy

Delving into the principles, modalities, and advancements in insulin replacement therapy for diabetes management, encompassing insulin types, administration techniques, dose titration, and strategies to optimize glycemic control while minimizing hypoglycemia and other adverse effects. Practical strategies for patient education, adherence, and optimizing glycemic control will be highlighted.

Track 5: Pediatric Endocrinology

Addressing the unique aspects of diagnosing, treating, and managing endocrine disorders in pediatric populations, encompassing growth disorders, puberty-related issues, congenital adrenal hyperplasia, diabetes, and other hormone-related conditions. Leading pediatric endocrinologists will present the latest research, clinical guidelines, and innovative treatment approaches tailored to the pediatric population.

• Growth Disorders
• Diabetes in Children
• Genetic Syndromes

Track 6: Neuroendocrinology

Exploring the intricate interplay between the endocrine system and the central nervous system, elucidating neuroendocrine pathways, and their roles in regulating homeostasis, stress responses, mood, behavior, and reproductive function. Participants will gain insights into the regulatory mechanisms governing hormone secretion and the impact of the central nervous system on endocrine function.

• Neuroendocrine Disorders
• Stress Response
• Neurotransmitters
• Hypothalamus-Pituitary Axis
• Hormonal Regulation

Track 7: Endocrine Glands

Delving into the latest advancements in basic and translational research focused on elucidating the physiology, pathophysiology, and therapeutic targets of endocrine glands, spanning from molecular mechanisms to clinical applications. Participants will learn about the major endocrine glands, including the thyroid, adrenal, pituitary, and pancreas, and their hormone secretions.

• Types of Glands
• Molecular Biology
• Signal Transduction
• Therapeutics

Track 8: Reproductive Endocrinology

Investigating the hormonal regulation of reproductive function, fertility, menstrual health, and sexual development, as well as the diagnosis and treatment of disorders affecting the reproductive system in both men and women. This session is crucial for healthcare professionals and researchers seeking to enhance their knowledge and improve patient outcomes in reproductive health and endocrinology.

• Menstrual Disorders
• Polycystic Ovary Syndrome
• Infertility
• Hormone Replacement Therapy
• Reproductive Endocrine Disorders
• Assisted Reproductive Technologies

Track 9: Thyroid Imbalance Insights

Providing insights into the spectrum of thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, exploring diagnostic modalities, treatment options, and considerations for personalized management. The session will also address the challenges of managing thyroid imbalances in special populations, including pregnant women and the elderly.

• Autoimmune Thyroid Disorders
• Treatment Options
• Thyroid Function Tests

Track 10: Endocrine Disorders

Surveying the landscape of various endocrine disorders, beyond diabetes and thyroid conditions, including adrenal, pituitary, gonadal, and parathyroid disorders, highlighting their clinical presentations, diagnostic approaches, and management strategies. This session is crucial for healthcare professionals dedicated to advancing their understanding and treatment of endocrine diseases.

• Pancreatic Disorders
• Genetic Endocrine Disorders
• Diabetes Mellitus

Track 11: Metabolic Syndrome

Investigating the constellation of metabolic abnormalities underlying metabolic syndrome, including central obesity, dyslipidemia, hypertension, and insulin resistance, and discussing the implications for cardiovascular risk assessment and targeted interventions. The session will cover evidence-based interventions such as lifestyle modifications, pharmacotherapy, and novel therapies aimed at managing and preventing metabolic syndrome and its associated complications.

• Abdominal Obesity
• Dyslipidemia
• High Blood Sugar

Track 12: Mental Health in Endocrine Care

Examining the bidirectional relationship between mental health disorders and endocrine conditions, addressing the impact of hormonal imbalances on mood, cognition, and behavior, and integrating mental health considerations into comprehensive endocrine care. Participants will examine how conditions such as diabetes, thyroid disorders, and adrenal dysfunction can influence mental health outcomes such as depression, anxiety, and cognitive function.

• Psychological Impact
• Emotional Well-being
• Psychiatric Comorbidities

Track 13: Endocrine Oncology

Scrutinizing the diagnosis, staging, treatment modalities, and multidisciplinary management of endocrine-related malignancies, encompassing thyroid, adrenal, pituitary, and neuroendocrine tumors, and addressing emerging therapeutic approaches and challenges. Expert speakers will discuss the latest advancements in oncology research, including molecular diagnostics, targeted therapies, and immunotherapy approaches specific to endocrine malignancies.

• Thyroid Cancer
• Adrenal Tumors
• Pituitary Tumors
• Parathyroid Cancer
• Neuroendocrine Tumors
• Endocrine Pancreatic Tumors
• Surgical Interventions

Track 14: Endocrine Genomics Essentials

Providing foundational insights into the role of genetics and genomics in shaping endocrine function, disorders, and personalized therapeutic strategies, highlighting key genetic variants, genomic technologies, and implications for precision medicine. This session is essential for healthcare professionals seeking to enhance their understanding of genetic influences on endocrine health and disease.

• Genetic Screening
• Gene Expression Profiling
• Pharmacogenomics
• Genetic Counseling
• Polygenic Risk

Track 15: Radiological Approaches in Endocrinology

Exploring the utility, indications, and interpretations of various radiological imaging modalities in diagnosing and monitoring endocrine disorders, from ultrasound to nuclear medicine, and discussing advancements in radiological techniques and their applications. Participants will explore a variety of radiological modalities such as ultrasound, CT scan, MRI, nuclear medicine, and PET scans, emphasizing their applications in evaluating thyroid nodules, adrenal tumors, pituitary adenomas, and other endocrine conditions.

• Imaging Modalities
• Functional Imaging
• Image-Guided Interventions
• Multimodal Imaging

Track 16: Precision Medicine in Endocrine Practice

Delving into the paradigm shift toward personalized approaches to diagnosing, treating, and managing endocrine disorders, leveraging genomic, molecular, and clinical data to tailor interventions to individual patient characteristics and optimize outcomes. The session will highlight innovative strategies for risk prediction, treatment response prediction, and patient stratification, emphasizing the role of big data analytics and artificial intelligence in advancing precision medicine in endocrine practice.

Track 17: Dietary Interventions in Endocrinology

Investigating the impact of dietary factors and interventions on endocrine health, including nutritional approaches to diabetes management, weight loss, metabolic syndrome, and other hormone-related conditions, and exploring dietary guidelines and lifestyle modifications. Expert speakers will discuss the impact of macronutrients, micronutrients, and dietary patterns on hormonal regulation, insulin sensitivity, and metabolic pathways.

• Diabetes Management
• Weight Management
• Calcium and Vitamin D Supplementation
• Medical Nutrition Therapy
• Behavioral Counseling

Track 18: Remote Endocrine Care

Exploring the evolving landscape of telemedicine and remote monitoring in delivering endocrine care, encompassing virtual consultations, telehealth platforms, digital health technologies, and their implications for improving access, convenience, and patient outcomes. The session will address regulatory considerations, reimbursement policies, and ethical implications associated with remote endocrine consultations.

Track 19: Endo Case Challenges

Engaging participants in interactive case-based discussions to navigate complex clinical scenarios and diagnostic dilemmas encountered in endocrine practice, fostering critical thinking, problem-solving skills, and collaborative decision-making in real-world contexts. Healthcare providers will gain valuable practical knowledge, diagnostic strategies, and therapeutic insights to enhance their clinical practice and improve patient outcomes in challenging endocrine cases.

Participation Benefits

• Keynote Speaker: Deliver a presentation lasting 45-50 minutes, sharing insights as a prominent figure in the field.
• Speaker (Oral Presentation): Present findings for 25-30 minutes, showcasing individual research or expertise.
• Speaker (Workshop): Lead a workshop for 45-50 minutes, providing interactive learning experiences.
• Speaker (Special Session): Contribute to a special session for 45-50 minutes, alongside fellow experts.
• Speaker (Symposium): Engage in a symposium for more than 45 minutes, collaborating with multiple presenters.
• Delegate (Registration Only): Access all sessions and benefits upon registration.
• Poster Presenter: Showcase research through poster presentations, enjoying delegate benefits.
• Remote Attendance: Participate via video or e-poster presentation.
• Exhibitor: Display company products through booked booths of varying sizes.
• Media Partner, Sponsor, and Collaborator: Collaborate with the event, offering support and visibility.

Market Analysis

Endocrinology Meet 2024 will feature the latest developments in research, diagnosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique

DM affects an estimated 29.1 million people in the United States and is the 7th leading cause of death. It increases the all-cause mortality rate 1.8 times compared to persons without diagnosed diabetes. It Increases the risk of heart attack by 1.8 times, in addition to these human costs, the estimated total financial cost of DM in the United States in 2012 was $245 billion, which includes the costs of medical care, disability, and premature death.

The importance of both diabetes and their comorbidities will continue to increase as the population ages. Therapies that have proven to reduce microvascular and macrovascular complications will need to be assessed considering the newly identified comorbidities. 

Market value on Diabetic Research:

More than 150 million expected to have diabetes by 2040

According to the International Diabetes Federation, more than 100 million people have diabetes in China, more than any other country in the world. Recently the number of cases has increased rapidly in recent years and it is expected to reach 151 million by 2040.